Soft Tissue Neoplasms

"Soft Tissue Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.

Descriptor ID	D012983
MeSH Number(s)	C04.588.839
Concept/Terms	Soft Tissue Neoplasms Soft Tissue Neoplasms Neoplasm, Soft Tissue Neoplasms, Soft Tissue Soft Tissue Neoplasm

Below are MeSH descriptors whose meaning is more general than "Soft Tissue Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Soft Tissue Neoplasms [C04.588.839]

Below are MeSH descriptors whose meaning is related to "Soft Tissue Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Soft Tissue Neoplasms".

Soft Tissue Neoplasms
Muscle Neoplasms
Vascular Neoplasms

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Soft Tissue Neoplasms" by people in this website by year, and whether "Soft Tissue Neoplasms" was a major or minor topic of these publications.

Bar chart showing 370 publications over 30 distinct years, with a maximum of 23 publications in 2003

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1991	9	1	10
1992	13	0	13
1993	9	1	10
1994	21	1	22
1995	13	5	18
1996	8	2	10
1997	7	2	9
1998	10	3	13
1999	12	3	15
2000	12	2	14
2001	10	2	12
2002	16	2	18
2003	17	6	23
2004	7	2	9
2005	6	1	7
2006	8	3	11
2007	10	2	12
2008	13	2	15
2009	12	1	13
2010	10	4	14
2011	15	2	17
2012	10	2	12
2013	6	2	8
2014	9	0	9
2015	9	1	10
2016	9	0	9
2017	4	0	4
2018	15	1	16
2019	10	0	10
2020	7	0	7

Below are the most recent publications written about "Soft Tissue Neoplasms" by people in Profiles.

Weiss AR, Chen YL, Scharschmidt TJ, Chi YY, Tian J, Black JO, Davis JL, Fanburg-Smith JC, Zambrano E, Anderson J, Arens R, Binitie O, Choy E, Davis JW, Hayes-Jordan A, Kao SC, Kayton ML, Kessel S, Lim R, Meyer WH, Million L, Okuno SH, Ostrenga A, Parisi MT, Pryma DA, Randall RL, Rosen MA, Schlapkohl M, Shulkin BL, Smith EA, Sorger JI, Terezakis S, Hawkins DS, Spunt SL, Wang D. Pathological response in children and adults with large unresected intermediate-grade or high-grade soft tissue sarcoma receiving preoperative chemoradiotherapy with or without pazopanib (ARST1321): a multicentre, randomised, open-label, phase 2 trial. Lancet Oncol. 2020 08; 21(8):1110-1122.

View in: PubMed
Baumann BC, Bernstein KA, DeLaney TF, Simone CB, Kolker JD, Choy E, Levin WP, Weber KL, Muniappan A, Berman AT, Staddon A, Hartner L, Van Tine B, Hirbe A, Glatstein E, Hahn SM, Nagda SN, Chen YL. Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity. J Surg Oncol. 2020 Oct; 122(5):877-883.

View in: PubMed
Nemir S, Mericli AF, Adelman DM, Liu J, Feig BW, Lin PP, Roubaud MS. A reconstructive algorithm of oncologic defects of the upper trunk and shoulder girdle: Factors predicting complexity and outcomes. J Surg Oncol. 2020 Aug; 122(2):283-292.

View in: PubMed
Roland CL. Soft Tissue Tumors of the Extremity. Surg Clin North Am. 2020 Jun; 100(3):669-680.

View in: PubMed
Roland CL, Wong SL. Treatment for Advanced Soft Tissue Sarcoma: An Informative Neutral Trial. JAMA. 2020 04 07; 323(13):1251-1252.

View in: PubMed
de Aguiar MCF, de Noronha MS, Silveira RL, Araújo JAD, Werkema FS, Bell D, Caldeira PC. Epithelioid rhabdomyosarcoma: Report of the first case in the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020 Nov; 130(5):e308-e315.

View in: PubMed
Keung EZ, Burgess M, Salazar R, Parra ER, Rodrigues-Canales J, Bolejack V, Van Tine BA, Schuetze SM, Attia S, Riedel RF, Hu J, Okuno SH, Priebat DA, Movva S, Davis LE, Reed DR, Reuben A, Roland CL, Reinke D, Lazar AJ, Wang WL, Wargo JA, Tawbi HA. Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab. Clin Cancer Res. 2020 03 15; 26(6):1258-1266.

View in: PubMed
Lautz TB, Hayes-Jordan A. Recent progress in pediatric soft tissue sarcoma therapy. Semin Pediatr Surg. 2019 Dec; 28(6):150862.

View in: PubMed
Whittle SB, Hicks MJ, Roy A, Vasudevan SA, Reddy K, Venkatramani R. Congenital spindle cell rhabdomyosarcoma. Pediatr Blood Cancer. 2019 11; 66(11):e27935.

View in: PubMed
Bonvalot S, Rutkowski PL, Thariat J, Carrère S, Ducassou A, Sunyach MP, Agoston P, Hong A, Mervoyer A, Rastrelli M, Moreno V, Li RK, Tiangco B, Herraez AC, Gronchi A, Mangel L, Sy-Ortin T, Hohenberger P, de Baère T, Le Cesne A, Helfre S, Saada-Bouzid E, Borkowska A, Anghel R, Co A, Gebhart M, Kantor G, Montero A, Loong HH, Vergés R, Lapeire L, Dema S, Kacso G, Austen L, Moureau-Zabotto L, Servois V, Wardelmann E, Terrier P, Lazar AJ, Bovée JVMG, Le Péchoux C, Papai Z. NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2-3, randomised, controlled trial. Lancet Oncol. 2019 08; 20(8):1148-1159.

View in: PubMed

People

Explore

Similar Concepts

Top Journals